Ethosuximide Capsule, Liquid Filled
NDC Package 69452-152-20

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Ethosuximide capsules is a medication used alone or with other medications to prevent and control a certain type of seizure (absence or petit mal seizure). This formulation utilizes a capsule, liquid filled delivery system. Marketed by Bionpharma Inc., this product is identified by NDC 69452-152 and is authorized under FDA application ANDA040430.

Identification & Billing

NDC Package Code
69452-152-20
Package Description
100 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC
Product Code
69452-152
11-Digit Billing Format
69452015220
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk
RxCUI: 197682 - ethosuximide 250 MG Oral Capsule

Clinical Specifications

Proprietary Name
Ethosuximide
Non-Proprietary Name
Ethosuximide
Substance Name
Ethosuximide
Dosage Form
Capsule, Liquid Filled - A solid dosage form in which the drug is enclosed within a soluble, gelatin shell which is plasticized by the addition of a polyol, such as sorbitol or glycerin, and is therefore of a somewhat thicker consistency than that of a hard shell capsule; typically, the active ingredients are dissolved or suspended in a liquid vehicle.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
ETHOSUXIMIDE 250 mg/1
Pharmacologic Class
Usage Information
This medication is used alone or with other medications to prevent and control a certain type of seizure (absence or petit mal seizure). It works by controlling the abnormal electrical activity in the brain that occurs during a seizure.

Regulatory & Marketing

Labeler Name
Bionpharma Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA040430
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
10-21-2016
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69452-152-20 identifies a specific commercial package of 100 capsule, liquid filled in 1 bottle, plastic of Ethosuximide, a human prescription drug labeled by Bionpharma Inc.. This capsule, liquid filled is formulated for oral use and contains ethosuximide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bionpharma Inc. on October 21, 2016. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used alone or with other medications to prevent and control a certain type of seizure (absence or petit mal seizure). It works by controlling the abnormal electrical activity in the brain that occurs during a seizure.

How is this Bionpharma Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69452015220. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69452-152-20
11-Digit CMS (5-4-2)
69452-0152-20

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.